CVS Health Management
Management criteria checks 1/4
CVS Health's CEO is J. Joyner, appointed in Oct 2024, has a tenure of less than a year. total yearly compensation is $17.81M, comprised of 6.2% salary and 93.8% bonuses, including company stock and options. directly owns 0.004% of the company’s shares, worth MX$60.92M. The average tenure of the management team and the board of directors is 2.3 years and 2.1 years respectively.
Key information
J. Joyner
Chief executive officer
US$17.8m
Total compensation
| CEO salary percentage | 6.20% |
| CEO tenure | less than a year |
| CEO ownership | 0.004% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | US$5b |
| Dec 31 2024 | US$18m | US$1m | US$5b |
Compensation vs Market: J.'s total compensation ($USD17.81M) is above average for companies of similar size in the MX market ($USD5.47M).
Compensation vs Earnings: Insufficient data to compare J.'s compensation with company performance.
CEO
J. Joyner (59 yo)
Mr. J. David Joyner is President, CEO & Director of CVS Health Corporation from October 17, 2024 and served as Executive Vice President from January 30, 2023 to October 17, 2024 and was President of CVS Ca...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 6.5yrs | US$305.00k | 0.00033% MX$ 4.9m | |
| President | less than a year | US$17.81m | 0.0041% MX$ 60.9m | |
| EVP of Ventures and Chief Experience & Technology Officer | 2.8yrs | US$11.36m | 0.0034% MX$ 51.0m | |
| Executive VP & Chief People Officer | less than a year | US$6.85m | no data | |
| Executive VP & Group President | 3.5yrs | US$13.27m | 0.0037% MX$ 55.4m | |
| Senior Director of Business Development & CVS Health and Partner & Co-Founder | no data | no data | no data | |
| Executive VP & CFO | no data | no data | 0% MX$ 0 | |
| Senior VP | 6.5yrs | no data | 0.00089% MX$ 13.2m | |
| Executive VP & Chief Compliance Officer | no data | no data | no data | |
| Executive VP | 2.3yrs | US$11.89m | 0.0017% MX$ 25.5m | |
| Head of Markets of Healthcare Benefits | 3.3yrs | no data | no data | |
| Chief Sustainability Officer & Senior VP of Corporate Social Responsibility | 2.3yrs | no data | no data |
Experienced Management: CVS *'s management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 6.5yrs | US$305.00k | 0.00033% MX$ 4.9m | |
| President | less than a year | US$17.81m | 0.0041% MX$ 60.9m | |
| Independent Director | 1.6yrs | US$335.00k | 0.00090% MX$ 13.3m | |
| Independent Director | less than a year | US$167.50k | 0% MX$ 0 | |
| Independent Director | 14.3yrs | US$335.00k | 0.0023% MX$ 34.7m | |
| Independent Director | 18.2yrs | US$355.00k | 0.010% MX$ 147.6m | |
| Independent Director | 10.2yrs | US$335.00k | 0.00023% MX$ 3.4m | |
| Independent Director | less than a year | US$167.50k | 0.00083% MX$ 12.3m | |
| Independent Director | 6.5yrs | US$360.00k | 0.0032% MX$ 46.7m | |
| Independent Director | 2.7yrs | US$348.33k | 0.00094% MX$ 13.9m | |
| Director | less than a year | US$167.50k | 0.00034% MX$ 5.0m | |
| Lead Independent Director | 1.5yrs | US$335.00k | 0.0036% MX$ 53.8m |
Experienced Board: CVS *'s board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/27 05:19 |
| End of Day Share Price | 2025/05/27 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CVS Health Corporation is covered by 61 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Harshit Gupta | Accountability Research Corporation |
| Christopher Graja | Argus Research Company |
| Samuel Hudson | Atlantic Equities LLP |